nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2C9—Leflunomide—rheumatoid arthritis	0.0878	0.0987	CbGbCtD
Brompheniramine—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.0624	0.0702	CbGbCtD
Brompheniramine—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0589	0.0663	CbGbCtD
Brompheniramine—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0564	0.0635	CbGbCtD
Brompheniramine—CYP2C19—Prednisone—rheumatoid arthritis	0.0521	0.0586	CbGbCtD
Brompheniramine—CYP2E1—Dexamethasone—rheumatoid arthritis	0.0519	0.0584	CbGbCtD
Brompheniramine—CYP2B6—Dexamethasone—rheumatoid arthritis	0.0512	0.0576	CbGbCtD
Brompheniramine—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0494	0.0556	CbGbCtD
Brompheniramine—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0416	0.0468	CbGbCtD
Brompheniramine—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0411	0.0462	CbGbCtD
Brompheniramine—CYP2C8—Dexamethasone—rheumatoid arthritis	0.0388	0.0436	CbGbCtD
Brompheniramine—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0376	0.0423	CbGbCtD
Brompheniramine—CYP2C19—Dexamethasone—rheumatoid arthritis	0.0325	0.0366	CbGbCtD
Brompheniramine—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0315	0.0355	CbGbCtD
Brompheniramine—CYP2C9—Dexamethasone—rheumatoid arthritis	0.0271	0.0304	CbGbCtD
Brompheniramine—CYP3A4—Betamethasone—rheumatoid arthritis	0.027	0.0304	CbGbCtD
Brompheniramine—CYP3A4—Prednisolone—rheumatoid arthritis	0.0267	0.03	CbGbCtD
Brompheniramine—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0253	0.0285	CbGbCtD
Brompheniramine—CYP3A4—Prednisone—rheumatoid arthritis	0.0252	0.0283	CbGbCtD
Brompheniramine—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0247	0.0278	CbGbCtD
Brompheniramine—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0239	0.0269	CbGbCtD
Brompheniramine—CYP3A4—Dexamethasone—rheumatoid arthritis	0.0157	0.0177	CbGbCtD
Brompheniramine—Chloropyramine—PTK2—rheumatoid arthritis	0.00881	0.742	CrCbGaD
Brompheniramine—Mepyramine—SLC22A4—rheumatoid arthritis	0.00306	0.258	CrCbGaD
Brompheniramine—CHRM1—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.89e-05	0.000191	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—POMC—rheumatoid arthritis	1.88e-05	0.00019	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.88e-05	0.00019	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—POMC—rheumatoid arthritis	1.88e-05	0.000189	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—POMC—rheumatoid arthritis	1.87e-05	0.000189	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.86e-05	0.000188	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT1—rheumatoid arthritis	1.86e-05	0.000188	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT1—rheumatoid arthritis	1.85e-05	0.000187	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—POMC—rheumatoid arthritis	1.85e-05	0.000187	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT1—rheumatoid arthritis	1.85e-05	0.000187	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCL2—rheumatoid arthritis	1.84e-05	0.000186	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6R—rheumatoid arthritis	1.84e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCL2—rheumatoid arthritis	1.84e-05	0.000185	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL10—rheumatoid arthritis	1.83e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—LEP—rheumatoid arthritis	1.83e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT1—rheumatoid arthritis	1.83e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6R—rheumatoid arthritis	1.83e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCL2—rheumatoid arthritis	1.83e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL10—rheumatoid arthritis	1.83e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6R—rheumatoid arthritis	1.82e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL10—rheumatoid arthritis	1.82e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCL2—rheumatoid arthritis	1.81e-05	0.000183	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6R—rheumatoid arthritis	1.81e-05	0.000182	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL10—rheumatoid arthritis	1.8e-05	0.000182	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—FN1—rheumatoid arthritis	1.8e-05	0.000182	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6ST—rheumatoid arthritis	1.8e-05	0.000181	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	1.79e-05	0.00018	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.76e-05	0.000177	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.76e-05	0.000177	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CD80—rheumatoid arthritis	1.73e-05	0.000175	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—FN1—rheumatoid arthritis	1.73e-05	0.000174	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.72e-05	0.000174	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6ST—rheumatoid arthritis	1.72e-05	0.000174	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MED1—rheumatoid arthritis	1.71e-05	0.000173	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CAT—rheumatoid arthritis	1.7e-05	0.000172	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP3—rheumatoid arthritis	1.67e-05	0.000169	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—TYK2—rheumatoid arthritis	1.67e-05	0.000169	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CAT—rheumatoid arthritis	1.67e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP3—rheumatoid arthritis	1.67e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—TYK2—rheumatoid arthritis	1.67e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP3—rheumatoid arthritis	1.66e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—TYK2—rheumatoid arthritis	1.66e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CD80—rheumatoid arthritis	1.66e-05	0.000167	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MTHFR—rheumatoid arthritis	1.65e-05	0.000167	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP3—rheumatoid arthritis	1.65e-05	0.000166	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TYK2—rheumatoid arthritis	1.64e-05	0.000166	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	1.64e-05	0.000166	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—POMC—rheumatoid arthritis	1.64e-05	0.000166	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	1.63e-05	0.000165	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTK2—rheumatoid arthritis	1.61e-05	0.000163	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCL2—rheumatoid arthritis	1.61e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTK2—rheumatoid arthritis	1.6e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6R—rheumatoid arthritis	1.6e-05	0.000162	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.6e-05	0.000162	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.6e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTK2—rheumatoid arthritis	1.6e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.6e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.59e-05	0.000161	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	1.59e-05	0.000161	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	1.59e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTK2—rheumatoid arthritis	1.58e-05	0.00016	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL5—rheumatoid arthritis	1.58e-05	0.000159	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.58e-05	0.000159	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—POMC—rheumatoid arthritis	1.57e-05	0.000159	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL5—rheumatoid arthritis	1.57e-05	0.000159	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL5—rheumatoid arthritis	1.57e-05	0.000158	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CSF2—rheumatoid arthritis	1.55e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL5—rheumatoid arthritis	1.55e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CSF2—rheumatoid arthritis	1.55e-05	0.000156	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CSF2—rheumatoid arthritis	1.55e-05	0.000156	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCL2—rheumatoid arthritis	1.54e-05	0.000155	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.54e-05	0.000155	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6R—rheumatoid arthritis	1.54e-05	0.000155	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.53e-05	0.000155	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CSF2—rheumatoid arthritis	1.53e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.53e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2—rheumatoid arthritis	1.52e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2—rheumatoid arthritis	1.51e-05	0.000152	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SPP1—rheumatoid arthritis	1.46e-05	0.000148	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TYK2—rheumatoid arthritis	1.46e-05	0.000147	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SPP1—rheumatoid arthritis	1.46e-05	0.000147	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.46e-05	0.000147	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SPP1—rheumatoid arthritis	1.45e-05	0.000147	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.45e-05	0.000146	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.45e-05	0.000146	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CAT—rheumatoid arthritis	1.44e-05	0.000145	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SPP1—rheumatoid arthritis	1.44e-05	0.000145	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NOS3—rheumatoid arthritis	1.43e-05	0.000145	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.43e-05	0.000145	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.43e-05	0.000145	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR5—rheumatoid arthritis	1.42e-05	0.000144	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MTHFR—rheumatoid arthritis	1.42e-05	0.000143	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR5—rheumatoid arthritis	1.42e-05	0.000143	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR5—rheumatoid arthritis	1.41e-05	0.000143	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.4e-05	0.000142	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.4e-05	0.000141	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR5—rheumatoid arthritis	1.4e-05	0.000141	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TYK2—rheumatoid arthritis	1.4e-05	0.000141	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.4e-05	0.000141	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2RA—rheumatoid arthritis	1.39e-05	0.000141	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MTHFR—rheumatoid arthritis	1.39e-05	0.00014	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2—rheumatoid arthritis	1.39e-05	0.00014	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—C3—rheumatoid arthritis	1.39e-05	0.00014	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2—rheumatoid arthritis	1.39e-05	0.00014	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—C3—rheumatoid arthritis	1.39e-05	0.00014	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2—rheumatoid arthritis	1.38e-05	0.00014	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—C3—rheumatoid arthritis	1.38e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2RA—rheumatoid arthritis	1.38e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NOS3—rheumatoid arthritis	1.37e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2—rheumatoid arthritis	1.37e-05	0.000138	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—C3—rheumatoid arthritis	1.37e-05	0.000138	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—POMC—rheumatoid arthritis	1.32e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.32e-05	0.000133	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—LEP—rheumatoid arthritis	1.29e-05	0.000131	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—LEP—rheumatoid arthritis	1.29e-05	0.00013	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CAT—rheumatoid arthritis	1.29e-05	0.00013	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—LEP—rheumatoid arthritis	1.29e-05	0.00013	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—LEP—rheumatoid arthritis	1.27e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—rheumatoid arthritis	1.27e-05	0.000128	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FN1—rheumatoid arthritis	1.22e-05	0.000123	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—rheumatoid arthritis	1.22e-05	0.000123	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FN1—rheumatoid arthritis	1.22e-05	0.000123	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.22e-05	0.000123	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2—rheumatoid arthritis	1.21e-05	0.000123	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FN1—rheumatoid arthritis	1.21e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.21e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—rheumatoid arthritis	1.21e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6ST—rheumatoid arthritis	1.21e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ALB—rheumatoid arthritis	1.2e-05	0.000122	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	1.2e-05	0.000121	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FN1—rheumatoid arthritis	1.2e-05	0.000121	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.2e-05	0.000121	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.18e-05	0.000119	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.17e-05	0.000118	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CD80—rheumatoid arthritis	1.17e-05	0.000118	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CD80—rheumatoid arthritis	1.17e-05	0.000118	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—rheumatoid arthritis	1.16e-05	0.000117	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CD80—rheumatoid arthritis	1.16e-05	0.000117	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—rheumatoid arthritis	1.16e-05	0.000117	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—NOS3—rheumatoid arthritis	1.15e-05	0.000116	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CD80—rheumatoid arthritis	1.15e-05	0.000116	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—rheumatoid arthritis	1.15e-05	0.000116	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NFKB1—rheumatoid arthritis	1.14e-05	0.000115	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—POMC—rheumatoid arthritis	1.14e-05	0.000115	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK8—rheumatoid arthritis	1.12e-05	0.000113	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—POMC—rheumatoid arthritis	1.11e-05	0.000112	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—POMC—rheumatoid arthritis	1.11e-05	0.000112	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	1.11e-05	0.000112	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—POMC—rheumatoid arthritis	1.1e-05	0.000111	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—rheumatoid arthritis	1.1e-05	0.000111	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	1.09e-05	0.00011	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	1.09e-05	0.00011	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL2—rheumatoid arthritis	1.09e-05	0.00011	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6R—rheumatoid arthritis	1.08e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	1.08e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	1.08e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL2—rheumatoid arthritis	1.08e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6R—rheumatoid arthritis	1.08e-05	0.000109	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.07e-05	0.000108	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.07e-05	0.000108	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	1.07e-05	0.000108	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	1.07e-05	0.000108	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	1.07e-05	0.000108	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—rheumatoid arthritis	1.05e-05	0.000106	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—rheumatoid arthritis	1.04e-05	0.000105	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—rheumatoid arthritis	1.03e-05	0.000104	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—rheumatoid arthritis	1.01e-05	0.000102	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—rheumatoid arthritis	9.91e-06	0.0001	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	9.89e-06	9.98e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TYK2—rheumatoid arthritis	9.88e-06	9.97e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	9.87e-06	9.97e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	9.84e-06	9.94e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TYK2—rheumatoid arthritis	9.81e-06	9.91e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	9.79e-06	9.88e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	9.72e-06	9.81e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—rheumatoid arthritis	9.71e-06	9.8e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—rheumatoid arthritis	9.69e-06	9.79e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	9.66e-06	9.75e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—rheumatoid arthritis	9.63e-06	9.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—POMC—rheumatoid arthritis	9.62e-06	9.71e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	9.54e-06	9.63e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—rheumatoid arthritis	9.48e-06	9.57e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	9.07e-06	9.16e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—rheumatoid arthritis	9.06e-06	9.15e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—rheumatoid arthritis	8.88e-06	8.96e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—rheumatoid arthritis	8.77e-06	8.85e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—rheumatoid arthritis	8.6e-06	8.68e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—POMC—rheumatoid arthritis	8.59e-06	8.67e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	8.57e-06	8.65e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—rheumatoid arthritis	8.54e-06	8.62e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	8.46e-06	8.54e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	8.39e-06	8.47e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—rheumatoid arthritis	8.22e-06	8.3e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	8.19e-06	8.27e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—rheumatoid arthritis	8.18e-06	8.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—rheumatoid arthritis	8.16e-06	8.24e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	8.15e-06	8.23e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—rheumatoid arthritis	8.12e-06	8.2e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	8.09e-06	8.16e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	8.05e-06	8.12e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	7.9e-06	7.97e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—POMC—rheumatoid arthritis	7.83e-06	7.9e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—rheumatoid arthritis	7.83e-06	7.9e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—rheumatoid arthritis	7.8e-06	7.87e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—rheumatoid arthritis	7.78e-06	7.85e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	7.75e-06	7.83e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAT—rheumatoid arthritis	7.74e-06	7.81e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—rheumatoid arthritis	7.73e-06	7.8e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NFKB1—rheumatoid arthritis	7.69e-06	7.77e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	7.67e-06	7.75e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	7.67e-06	7.74e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	7.65e-06	7.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NFKB1—rheumatoid arthritis	7.65e-06	7.72e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	7.57e-06	7.64e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK8—rheumatoid arthritis	7.56e-06	7.64e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	7.54e-06	7.61e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK8—rheumatoid arthritis	7.52e-06	7.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	7.49e-06	7.56e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—rheumatoid arthritis	7.47e-06	7.54e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	7.44e-06	7.51e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	7.2e-06	7.27e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—rheumatoid arthritis	7.14e-06	7.21e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—rheumatoid arthritis	7.14e-06	7.21e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—rheumatoid arthritis	6.98e-06	7.05e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	6.96e-06	7.03e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—rheumatoid arthritis	6.94e-06	7e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	6.89e-06	6.95e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	6.87e-06	6.94e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	6.85e-06	6.91e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—rheumatoid arthritis	6.84e-06	6.9e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	6.83e-06	6.89e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	6.46e-06	6.52e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—rheumatoid arthritis	6.41e-06	6.47e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	6.39e-06	6.45e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—rheumatoid arthritis	6.37e-06	6.43e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	6.31e-06	6.37e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	6.3e-06	6.36e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	6.24e-06	6.3e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—rheumatoid arthritis	5.28e-06	5.33e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	5.26e-06	5.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—rheumatoid arthritis	5.24e-06	5.29e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	5.19e-06	5.24e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—POMC—rheumatoid arthritis	5.16e-06	5.21e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—rheumatoid arthritis	4.83e-06	4.88e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	4.81e-06	4.86e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—rheumatoid arthritis	4.8e-06	4.84e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	4.75e-06	4.8e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—rheumatoid arthritis	4.71e-06	4.75e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	4.5e-06	4.55e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	4.12e-06	4.16e-05	CbGpPWpGaD
